Donate Help Contact The AHA Sign In Home
American Heart Association
Hypertension
Search: search_blue_button Advanced Search
Hypertension. 1993;21:956-960

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowRequest Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Nakamura, T.
Right arrow Articles by Granger, J. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Nakamura, T.
Right arrow Articles by Granger, J. P.

Hypertension, Vol 21, 956-960, Copyright © 1993 by American Heart Association


ARTICLES

Role of renal interstitial pressure as a mediator of sodium retention during systemic blockade of nitric oxide

T Nakamura, AM Alberola and JP Granger
Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson 39216-4505.

The role of renal interstitial pressure was examined in mediating the sodium retention induced by blockade of nitric oxide synthesis. The effects of intravenous NG-nitro-L-arginine-methyl ester (L-NAME), a synthesis inhibitor, on renal hemodynamics, renal interstitial hydrostatic pressure, and sodium and lithium excretion were determined. L-NAME (50 micrograms/kg per minute) was infused for 75 minutes in Sprague-Dawley rats (n = 7) in which renal perfusion pressure was permitted to rise in parallel with systemic arterial pressure and in rats (n = 8) in which renal perfusion pressure was serocontrolled constant at basal levels. Infusion of L-NAME raised renal perfusion pressure from 122 +/- 6 to 157 +/- 4 mm Hg in the nonservocontrolled group but not in the servocontrolled group (118 +/- 3 mm Hg). L-NAME decreased renal plasma flow and glomerular filtration rate to the same level in both rat groups. L-NAME significantly decreased sodium excretion (1.38 +/- 0.41 to 0.36 +/- 0.14 microEq/min and 1.19 +/- 0.46 to 0.30 +/- 0.05 microEq/min, respectively), fractional excretion of lithium (25.7 +/- 1.7% to 16.7 +/- 2.3% and 25.6 +/- 4.0% to 18.2 +/- 1.7%), and renal interstitial hydrostatic pressure (6.4 +/- 1.4 to 3.2 +/- 0.9 mm Hg and 6.3 +/- 1.8 to 2.7 +/- 0.9 mm Hg) in servocontrolled and nonservocontrolled groups. However, there was no significant difference in the renal hemodynamic and excretory responses to L-NAME between the servocontrolled and nonservocontrolled groups. In summary, reductions in sodium excretion during inhibition of nitric oxide synthesis are associated with significant reductions in renal interstitial hydrostatic pressure.(ABSTRACT TRUNCATED AT 250 WORDS)


This article has been cited by other articles:


Home page
HypertensionHome page
D. C. Lieb, B. A. Kemp, N. L. Howell, J. J. Gildea, and R. M. Carey
Reinforcing Feedback Loop of Renal Cyclic Guanosine 3' 5' -Monophosphate and Interstitial Hydrostatic Pressure in Pressure-Natriuresis
Hypertension, December 1, 2009; 54(6): 1278 - 1283.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
T. V. Peterson, C. Emmeluth, and P. Bie
Renal effects of nitric oxide synthase inhibition in conscious water-loaded dogs
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2001; 281(2): R584 - R590.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
X. C. Wu, P. J. Harris, and E. J. Johns
Nitric oxide and renal nerve-mediated proximal tubular reabsorption in normotensive and hypertensive rats
Am J Physiol Renal Physiol, October 1, 1999; 277(4): F560 - F566.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
K. Fujiwara, K. Hayashi, H. Matsuda, E. Kubota, M. Honda, Y. Ozawa, and T. Saruta
Altered Pressure-Natriuresis in Obese Zucker Rats
Hypertension, June 1, 1999; 33(6): 1470 - 1475.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
A. Broere, A. H. Van Den Meiracker, F. Boomsma, F. H. M. Derkx, A. J. Man In'T Veld, and M. A. D. H. Schalekamp
Human renal and systemic hemodynamic, natriuretic, and neurohumoral responses to different doses of L-NAME
Am J Physiol Renal Physiol, December 1, 1998; 275(6): F870 - F877.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Renal Physiol.Home page
S. Y. Chin, C.-T. Wang, D. S. A. Majid, and L. G. Navar
Renoprotective effects of nitric oxide in angiotensin II-induced hypertension in the rat
Am J Physiol Renal Physiol, May 1, 1998; 274(5): F876 - F882.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Cell Physiol.Home page
E. Eitle, S. Hiranyachattada, H. Wang, and P. J. Harris
Inhibition of proximal tubular fluid absorption by nitric oxide and atrial natriuretic peptide in rat kidney
Am J Physiol Cell Physiol, April 1, 1998; 274(4): C1075 - C1080.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
M. T. Llinas, J. D. Gonzalez, F. Rodriguez, E. Nava, S. Taddei, and F. J. Salazar
Renal Changes Induced by Nitric Oxide and Prostaglandin Synthesis Reduction : Effects of Trandolapril and Verapamil
Hypertension, February 1, 1998; 31(2): 657 - 664.
[Abstract] [Full Text] [PDF]


Home page
HypertensionHome page
F. J. Fenoy, P. Ferrer, L. Carbonell, and M. Garcia-Salom
Role of Nitric Oxide on Papillary Blood Flow and Pressure Natriuresis
Hypertension, March 1, 1995; 25(3): 408 - 414.
[Abstract] [Full Text]